Literature DB >> 19770369

Is preoperative chemoradiotherapy still the treatment of choice for rectal cancer?

Bruce D Minsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19770369     DOI： 10.1200/JCO.2009.22.9112

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  A gene expression signature for chemoradiosensitivity of colorectal cancer cells.

Authors:  Melanie Spitzner; Georg Emons; Frank Kramer; Jochen Gaedcke; Margret Rave-Fränk; Jens-Gerd Scharf; Peter Burfeind; Heinz Becker; Tim Beissbarth; B Michael Ghadimi; Thomas Ried; Marian Grade
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-11-15       Impact factor: 7.038

2.  β-catenin and Her2/neu expression in rectal cancer: association with histomorphological response to neoadjuvant therapy and prognosis.

Authors:  Uta Drebber; Martin Madeja; Margarete Odenthal; Inga Wedemeyer; Stefan P Mönig; Jan Brabender; Elfriede Bollschweiler; Arnulf H Hölscher; Paul M Schneider; Hans P Dienes; Daniel Vallböhmer
Journal:  Int J Colorectal Dis       Date:  2011-05-03       Impact factor: 2.571

3.  Clinical significance of tumor regression grade in rectal cancer with preoperative chemoradiotherapy.

Authors:  Young Joo Park; Byung Ryul Oh; Sang Woo Lim; Jung Wook Huh; Jae Kyun Joo; Young Jin Kim; Hyeong Rok Kim
Journal:  J Korean Soc Coloproctol       Date:  2010-08-31

4.  Preoperative assessment of lymph node metastasis in clinically node-negative rectal cancer patients based on a nomogram consisting of five clinical factors.

Authors:  Chi Zhou; Hua-Shan Liu; Xuan-Hui Liu; Xiao-Bin Zheng; Tuo Hu; Zhen-Xing Liang; Xiao-Wen He; Xiao-Sheng He; Jian-Cong Hu; Xiao-Jian Wu; Xian-Rui Wu; Ping Lan
Journal:  Ann Transl Med       Date:  2019-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.